Supriya Lifescience Limited has intimated the stock exchanges about an upcoming Board of Directors meeting scheduled for Thursday, August 13, 2026. The primary agenda of this meeting is to consider and approve the company's Unaudited Financial Results for the quarter ended June 30, 2026 (Q1 FY2027).
This disclosure is made in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company has also notified that in accordance with its Code of Conduct for Prevention of Insider Trading, the trading window for designated persons and their immediate relatives remains closed. The closure period began on July 1, 2026 and will continue until 48 hours after the declaration of the unaudited financial results on August 13, 2026.
The communication was digitally signed by Prachi Suhas Sathe, Company Secretary & Compliance Officer, on August 06, 2026 at 18:10:31 IST.
Factory Information
- Address: A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India
- Fax: +91 2356 272178